Buffett, Bloomberg, & 48 Congress Members Are Buying 1 Sector
Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, "The Walmart Family", Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market... The last time we saw the world's wealthiest investors move their cash into this corner of the market, Stocks exploded 2,020%, 5,609% Even as high as 8,437% in just ONE year. Now, it's all happening again.
Companies tighten security after a health care CEO's killing leads to a surge of threats
“Wanted” posters with the names and faces of health care executives have been popping up on the streets of New York. Hit lists with images of bullets are circulating online with warnings that industry leaders should be afraid.
Elon Musk Vs. RFK Jr.: Obesity Crisis Debate Sparks Struggle For Trump's Influence
Debate over tackling U.S. obesity epidemic sparks contrasting views from Trump's orbit: lifestyle changes vs. easier access to weight-loss drugs.
Did You See Trump's Bombshell Exec. Order 001? - Ad
Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." It's a bombshell law that Trump could sign within minutes of stepping into the Oval Office... And it will instantly set off the most sweeping government technology project in 80 years... The most lucrative, too...
DOJ files complaint against CVS for facilitating unlawful sale of prescription opioids
The Justice Department unsealed a civil complaint Wednesday alleging CVS Pharmacy Inc. and various subsidiaries filled “unlawful” prescriptions in violation of the federal Controlled Substances Act.
Bipartisan Lawmakers Aim To Break Up Health Care Giants With New Legislation
Pharmacy-benefit managers (PBMs) have been scrutinized for their role in drug distribution for years. Now a bipartisan group of lawmakers is threatening to break up the companies behind these so-called drug middlemen.
Donald Trump Is About to Free Crypto From Its Chains... - Ad
This coin may be Trump's favorite crypto... And his vice-president J.D. Vance is a major backer. With the pair set to take office, we don't think this coin's future could be brighter.
UnitedHealthcare CEO's shooting opens a door for many to vent frustrations over insurance
For years, patients in the U.S. health care system have grown frustrated with .
FDA says decongestant in many cold medicines doesn't work. So what does?
WASHINGTON (AP) — Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading decongestant found in hundreds of over-the-counter medicines, concluding that it doesn’t actually relieve nasal congestion.
Is This Defi Coin Your Next "10-Bagger" Investment? - Ad
Our #1 pick in decentralized finance is largely overlooked by mainstream investors (for now). This governance token could skyrocket as DeFi adoption surges with the smart money and institutions.
FDA Approves Ionis Pharmaceuticals' Rare Genetic Disease Therapy to Lower High-Level Of Fat In Blood
Ionis' Tryngolza receives FDA approval for familial chylomicronemia syndrome, showing significant triglyceride reduction and fewer pancreatitis events.
FDA says knockoff versions of Lilly obesity drug must come off the market
WASHINGTON (AP) — Specialty pharmacies and online companies that have been selling off-brand copies of two blockbuster drugs for obesity and diabetes will need to phase out their versions next year under a federal decision issued Thursday.
"This Will Be Worse Than the Great Depression, the Dot-Com Crash, and the 2008 Crisis Combined" - Ad
According to Dan Ferris, who has predicted nearly every major market crisis of the last 25 years, a new crisis in the US economy could soon cost you 50% of your portfolio or more if you don't prepare your wealth now. Especially if you're sitting on large gains.
Mesoblast's Cell Therapy Treatment For Graft Versus Host Disease Gets FDA Approval, Stock Surges
Mesoblast's Ryoncil is now FDA-approved for pediatric SR-aGvHD, marking a milestone in mesenchymal stromal cell therapies in the U.S.
Wisconsin's tight Republican majority sparks hope for bipartisan cooperation
MADISON, Wis. (AP) — When the Wisconsin Legislature returns to work in January, Republicans will still be in charge but will have the since taking control in 2011. That's giving Democrats, including Gov. Tony Evers, optimism that both sides will be able to work together better than they have since Evers took office six years ago.
There's One Thing Trump and Musk Can't Fix - Ad
Donald Trump and Elon Musk are teaming up to fix America's broken government. With the launch of the Department of Government Efficiency, they're planning to cut $2 trillion from the federal budget. But sadly, there's ONE thing Trump and Musk can't fix.
What's Going On With Larimar Therapeutics Stock On Tuesday?
Larimar Therapeutics reports promising FXN level increases with 25 mg nomlabofusp, advancing towards dose escalation for Friedreich's Ataxia treatment.
Who wants a pig organ? Patients sick and tired of waiting years for a transplant
LOUISVILLE, Ky. (AP) — The calls and emails started coming into and soon after doctors began experimenting with pig organs in humans.
5 Military Stocks to Invest In - Ad
As violence spreads across the globe will you stay on the sidelines? We can't stop war, but you can win from it. These 5 military growth stocks could potentially build your personal wealth during global turmoil. Historically, similar stocks have seen growth of up to 16,270% in just 18 months.
New Jersey weighs making underage gambling no longer a crime, but subject to a fine
TRENTON, N.J. (AP) — Should underage gambling no longer be a crime?
As US Faces Shortage Of Expensive Skilled Clinicians, Home-Based Health Service Provider Addus HomeCare Is Well-Positioned To Grow: Analyst
JMP Securities begins coverage of Addus HomeCare Corp with a $150 price target, highlighting expansion plans, strategic acquisitions, and strong revenue growth.
There's Only ONE AI Company That Matters - Ad
It's not Nvidia, AMD, IBM, or any new startup. It's not even an artificial intelligence company... yet it holds the key to the entire AI market. Get all the details of the critical technology that the entire AI sector needs to survive.
Novo Nordisk's Ozempic Potentially Linked To Rare Vision Loss Risk, But Absolute Risk Is Low: Study
Semaglutide use in diabetes patients is linked to a higher risk of NAION, a rare eye condition. A Danish-Norwegian study shows a low absolute risk despite significant association.
Florida woman charged with threatening health insurance company with 'delay, deny, depose'
LAKELAND, Fla. (AP) — A Florida woman has been charged with threatening her health insurance provider during a phone conversation after police say she uttered the same words found on the bullet casings used in the in New York.
The Secret to Trading Success? It's Simpler Than You Think - Ad
Forget fancy software. Top traders rely on free alerts that tell them when to jump on the next big trade. Straight to your phone. No guessing, no stress.
US says $365 million is available to install solar and battery storage systems in Puerto Rico
SAN JUAN, Puerto Rico (AP) — The U.S. Department of Energy said Thursday that $365 million is available to install solar and battery storage systems in homes and healthcare centers across Puerto Rico.
Ontario to restrict electricity exports to US and bar American-made alcohol if Trump tariffs applied
TORONTO (AP) — Canada’s most populous province may bar American-made alcohol in addition to restricting electricity exports to Michigan, New York State and Minnesota if President-elect Donald Trump imposes sweeping tariffs on all Canadian products, a senior official said Thursday.
A Strange Twist Is About to Hit the AI Market That Almost Nobody Sees Coming... - Ad
If you have any money in AI stocks right now, or if you're even thinking about it, you need to see what's going on. The truth is, the moves we've seen in tech and AI stocks over the last couple of months could be the start of something much bigger. That's why I've put together this special presentation with Wall Street legend, Charles Mizrahi.
NYPD Warns About 'Wanted' Posters Targeting Executives, Including AmEx CEO's Image And Crossed-Out UnitedHealth CEO
The NYPD has issued a warning about threats to healthcare executives following the murder of UnitedHealth CEO Brian Thompson, highlighting the circulation of "Wanted" posters and rising security concerns amidst extremist reactions online.
The Latest: UnitedHealthcare CEO shooting suspect contests his extradition back to New York
, suspect in the , contested his extradition back to New York at a court hearing Tuesday, though it isn’t expected to delay legal proceedings significantly.
Scary Accurate AI Money Map Shows Strange Twist Coming for the Market - Ad
Over the last 5 years, this "scary accurate" AI Money Map has helped investors get in on the right stocks, at the right time -- during this AI revolution... Now it shows a strange twist is coming for the AI market that almost nobody sees coming... And worse still, no one's being warned about.
Arvinas-Pfizer Partner Cancer Drug Trial Shows 63% Clinical Benefit In Breast Cancer Patients
Arvinas and Pfizer share Phase 1b TACTIVE-U trial results showing 62.5% clinical benefit rate and tolerable safety for advanced breast cancer therapy.
Biogen Downgraded On Pipeline Setbacks And Leqembi Sales Slowdown
Jefferies downgrades Biogen with a reduced price target, citing pipeline setbacks, slow Leqembi sales, and challenges from declining Ocrevus royalties.
"King of the Quants": Please Don't Take This Warning Lightly... - Ad
My system has recently uncovered a market phenomenon I haven't seen in 30 years.Some fortunate folks like me built generational wealth back then...while others lost their shirts and spent decades trying to recover. Well, something similar is happening today... but it will end in a much bigger way. This market shakeup is going to be much more intense.
Arcellx's Cancer Cell Therapy Shows Deep, Durable Responses With Manageable Safety Profile In Heavily Pretreated Blood Cancer Patients
Arcellx's Phase 2 trial of anito-cel in relapsed multiple myeloma reveals high response rates and manageable safety, with durable patient outcomes.
How should the opioid settlements be spent? Those hit hardest often don’t have a say
People with substance use disorder across the country are not getting a formal say in how most of the approximately $50 billion in is being used to stem the crisis, a new analysis found.
Man Who Predicted Trump 2016-2024: Secret Executive Order Will Disrupt Financial Markets - Ad
Jim Rickards, famed Trump 2016-2024 predictor and CIA advisor, just dropped a new bombshell: a secret executive order could disrupt markets. His latest prediction has major implications for your financial future.
Why Is BioNTech Stock Trading Higher On Friday?
BNT324/DB-1311 trial data show significant antitumor activity in various cancers, with high response rates in small cell lung and prostate cancer patients.
The Latest: Hunt for the gunman who killed UnitedHealthcare’s CEO heads into its third day
The investigation into and search for the masked gunman who the head of UnitedHealthcare has moved into its third day. Possible leads have emerged about his travel before the shooting and a message scrawled on ammunition found at the crime scene.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.